Literature DB >> 23040710

Changes in bone mineral density after surgical intervention for primary hyperparathyroidism.

Benzon M Dy1, Clive S Grant, Robert A Wermers, Ann E Kearns, Marianne Huebner, William S Harmsen, Geoffrey B Thompson, David R Farley, Melanie L Richards.   

Abstract

BACKGROUND: Patients with primary hyperparathyroidism often lack classic symptoms but can have reductions in bone mineral density and increased fracture risk. We sought to determine bone mineral density improvement after successful surgery and associated factors.
METHODS: A review of patients with osteopenia or osteoporosis with curative parathyroidectomy and both pre- and postoperative dual-energy X-ray absorptiometry bone mineral density scans was conducted. We compared patients with declining (<0%), moderate improvement (0.1-5%), and significant improvement (>5%) on dual-energy X-ray absorptiometry bone mineral density scans.
RESULTS: We identified 420 patients who underwent a dual-energy X-ray absorptiometry bone mineral density scan preoperatively and within 36 months postoperatively. At the most affected site, 38% had significant improvement, 31% moderate improvement, and 31% declining bone mineral density. Patients who significantly improved were younger (P = .01), had lesser preoperative dual-energy X-ray absorptiometry (P = .001), and had greater preoperative levels of parathyroid hormone (P = .04), serum calcium (P = .03), and preoperative urinary calcium. There was no difference in outcomes between sex and with preoperative bisphosphonate use. Average hip and spine bone mineral density had similar responses to surgery.
CONCLUSION: Bone mineral density improves in up to 75% of patients after curative parathyroidectomy for primary hyperparathyroidism. The hip and lumbar spine responded similarly. Younger patients and those with severe primary hyperparathyroidism may derive the most skeletal benefits from parathyroidectomy, but the uniform positive response supports parathyroidectomy in patients with osteoporosis and possibly osteopenia.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23040710     DOI: 10.1016/j.surg.2012.08.015

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  10 in total

1.  Skeletal Microstructure and Estimated Bone Strength Improve Following Parathyroidectomy in Primary Hyperparathyroidism.

Authors:  Natalie E Cusano; Mishaela R Rubin; Barbara C Silva; Yu-Kwang Donovan Tay; John M Williams; Sanchita Agarwal; Beatriz Omeragic; X Edward Guo; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2018-01-01       Impact factor: 5.958

2.  Contemporary surgical treatment of primary hyperparathyroidism without intraoperative parathyroid hormone measurement.

Authors:  O A Mownah; G Pafitanis; W M Drake; J N Crinnion
Journal:  Ann R Coll Surg Engl       Date:  2015-11       Impact factor: 1.891

3.  Predictors of bone mineral density improvement in patients undergoing parathyroidectomy for primary hyperparathyroidism.

Authors:  Jyotirmay Sharma; Dina S Itum; Lewis Moss; C Li; Christine Chun-Li; Collin Weber
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

4.  Impaired calcium sensing distinguishes primary hyperparathyroidism (PHPT) patients with low bone mineral density.

Authors:  Thomas J Weber; James Koh; Samantha M Thomas; Joyce A Hogue; Randall P Scheri; Sanziana A Roman; Julie A Sosa
Journal:  Metabolism       Date:  2017-06-19       Impact factor: 8.694

5.  Predictors of teriparatide treatment failure in patients with low bone mass.

Authors:  Tarig Elraiyah; Adil H Ahmed; Zhen Wang; Joshua N Farr; Mohammad H Murad; Matthew T Drake
Journal:  Bone Rep       Date:  2015-11-17

6.  Gender differences in bone mineral density in patients with sporadic primary hyperparathyroidism.

Authors:  Danica M Vodopivec; Angelica M Silva; Dinamarie C Garcia-Banigan; Ioannis Christakis; Ashley Stewart; Kelly Schwarz; Caroline S Hussey; Roland Bassett; Mimi I Hu; Nancy D Perrier
Journal:  Endocrinol Diabetes Metab       Date:  2018-09-04

7.  Effectiveness of anti-osteoporotic treatment after successful parathyroidectomy for primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial.

Authors:  Martin B Niederle; Ursula Foeger-Samwald; Philipp Riss; Andreas Selberherr; Christian Scheuba; Peter Pietschmann; Bruno Niederle; Katharina Kerschan-Schindl
Journal:  Langenbecks Arch Surg       Date:  2019-08-26       Impact factor: 3.445

8.  Changes in bone mineral density after parathyroidectomy in patients with moderate to severe primary hyperparathyroidism.

Authors:  Shuai Lu; Maoqi Gong; Yejun Zha; Aimin Cui; Chen Chen; Hao Yang; Weitong Sun; Kehan Hua; Wei Tian; Xieyuan Jiang
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

9.  Changes in bone mineral density after total parathyroidectomy without autotransplantation in the end-stage renal disease patients with secondary hyperparathyroidism.

Authors:  Li Fang; Jining Wu; Jing Luo; Ping Wen; Mingxia Xiong; Jinlong Cao; Xiaolan Chen; Junwei Yang
Journal:  BMC Nephrol       Date:  2018-06-15       Impact factor: 2.388

10.  A study on the causes of operative failures after microwave ablation for primary hyperparathyroidism.

Authors:  Wei Ying; Zhao Zhen-Long; Cao Xiao-Jing; Peng Li-Li; Li Yan; Yu Ming-An
Journal:  Eur Radiol       Date:  2021-03-02       Impact factor: 5.315

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.